ANIK - Anika Therapeutics, Inc.
IEX Last Trade
16.24
0.050 0.308%
Share volume: 357
Last Updated: Fri 27 Dec 2024 08:28:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$16.19
0.05
0.31%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-09 | 2023-03-16 | 2023-05-09 | 2023-08-08 | 2023-11-03 | 2024-03-15 | 2024-05-08 | |
| Total revenue | 39.657 M | 40.264 M | 39.622 M | 37.924 M | 44.302 M | 41.465 M | 42.971 M | 40.523 M | |
| Cost of revenue | 14.795 M | 17.485 M | 15.491 M | 15.081 M | 15.330 M | 16.521 M | 16.642 M | 15.895 M | |
| Gross profit | 24.862 M | 22.779 M | 24.131 M | 22.843 M | 28.972 M | 24.944 M | 26.329 M | 24.628 M | |
| -8.38% | 5.94% | -5.34% | 26.83% | -13.90% | 5.55% | -6.46% | |||
| Operating expenses | 28.243 M | 28.577 M | 30.798 M | 35.396 M | 32.603 M | 32.618 M | 27.920 M | 29.691 M | |
| Selling general and admin | 21.268 M | 21.276 M | 23.049 M | 26.996 M | 23.689 M | 24.827 M | 20.335 M | 21.527 M | |
| Research and development | 6.975 M | 7.301 M | 7.749 M | 8.400 M | 8.914 M | 7.791 M | 7.585 M | 8.164 M | |
| Total expenses | 43.038 M | 46.062 M | 46.289 M | 50.477 M | 47.933 M | 49.139 M | 44.562 M | 45.586 M | |
| 7.03% | 0.49% | 9.05% | -5.04% | 2.52% | -9.31% | 2.30% | |||
| Operating income | -3.381 M | -5.798 M | -6.667 M | -12.553 M | -3.631 M | -7.674 M | -1.591 M | -5.063 M | |
| Ebit | -3.381 M | -5.798 M | -6.667 M | -12.553 M | -3.631 M | -7.674 M | -1.591 M | -5.063 M | |
| Pretax income | -3.285 M | -5.362 M | -6.391 M | -12.014 M | -3.070 M | -7.039 M | -63.204 M | -4.471 M | |
| 63.23% | 19.19% | 87.98% | -74.45% | 129.28% | 797.91% | -92.93% | |||
| Income tax | -442.000 K | -1.187 M | -1.483 M | -1.664 M | -329.000 K | -463.000 K | -204.000 K | 43.000 K | |
| Net income basic | -2.843 M | -4.175 M | -4.908 M | -10.350 M | -2.741 M | -6.576 M | -63.000 M | -4.514 M | |
| -46.85% | -17.56% | -110.88% | 73.52% | -139.91% | -858.03% | 92.83% | |||
| Net income | -2.843 M | -4.175 M | -4.908 M | -10.350 M | -2.741 M | -6.576 M | -63.000 M | -4.514 M | |
| -46.85% | -17.56% | -110.88% | 73.52% | -139.91% | -858.03% | 92.83% |